请输入您的用户名或电子邮件地址。您将收到一个链接,通过电子邮件创建一个新密码。
© 2023 MergersCorp M&A International. © 2022 MergersCorp™ M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://www.mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
该公司在哥伦比亚市场已有 19 年的历史,拥有已获批准的 INVIMA 注册。
与一家大经销商进行了认真的对话,以将市场扩展到危地马拉和中美洲的另外 5 个国家。在哥伦比亚的所有主要城市和许多二级城市有 289 家附属药店。 CRM 组织得非常好,在医生、药房和机构市场之间拥有 1397 名成员。在哥伦比亚的所有主要城市和许多二级城市有 289 家附属药店。
该公司购买原料药、赋形剂、包装和产品,一切都由哥伦比亚经 INVIMA 批准的专业工厂外包生产。
目前,有32个产品获得INVIMA和工商总局的注册和批准。两款新产品即将获得英威马批准。
哥伦比亚 INVIMA 的批准平均需要 2 年时间和 30.000 美元的投资才能实现。
该企业有 5 种营养产品,其中我们拥有品牌,但没有注册。
o 抗生素
o 镇痛药
o 抗炎
o 抗组胺药
o 心血管
o 营养
o 胃肠病学
o 降脂药
o 儿科产品:抗生素和营养品。
Gross Revenue
$2,000,000
EBITDA
$450,000
Established
2002
Business ID:
L#20210109
Country
哥伦比亚
City:
波哥大
Business ID: | L#20210109 |
财产种类: | 制造业 |
物业状况: | 待售 |
Target Price: | $11,500,000 |
Gross Revenue: | $2,000,000 |
EBITDA: | $450,000 |
Target Price / Revenue: | 5.75x |
Target Price / EBITDA: | 25.56x |
Established: | 2002 |
Business Description: | 员工37人,其中16人在职,其余在不同城市提供服务。 |
Support & Training: | 6个月 |
Reason for Selling: | 退休 |
更新 7月 8, 2021 在 7:09 下午
该公司在哥伦比亚市场已有 19 年的历史,拥有已获批准的 INVIMA 注册。
与一家大经销商进行了认真的对话,以将市场扩展到危地马拉和中美洲的另外 5 个国家。在哥伦比亚的所有主要城市和许多二级城市有 289 家附属药店。 CRM 组织得非常好,在医生、药房和机构市场之间拥有 1397 名成员。在哥伦比亚的所有主要城市和许多二级城市有 289 家附属药店。
该公司购买原料药、赋形剂、包装和产品,一切都由哥伦比亚经 INVIMA 批准的专业工厂外包生产。
目前,有32个产品获得INVIMA和工商总局的注册和批准。两款新产品即将获得英威马批准。
哥伦比亚 INVIMA 的批准平均需要 2 年时间和 30.000 美元的投资才能实现。
该企业有 5 种营养产品,其中我们拥有品牌,但没有注册。
o 抗生素
o 镇痛药
o 抗炎
o 抗组胺药
o 心血管
o 营养
o 胃肠病学
o 降脂药
o 儿科产品:抗生素和营养品。
© 2023 MergersCorp M&A International © 2022 MergersCorp™ M&A International is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://www.mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.
This website is operated by MergersUS Inc.a US Corporation with registered office at 40th Wall Street, Suite #2725, New York, New York 10005, United States of America.
This website is operated by MergersUS Inc a US Corporation with registered office at